# Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea

> **NCT03064438** · PHASE2 · COMPLETED · sponsor: **Accuitis, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Acne Rosacea

## Interventions

- **DRUG:** ACCU-D1
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT03064438
- **Lead sponsor:** Accuitis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-28
- **Primary completion:** 2018-06-05
- **Final completion:** 2018-06-18
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03064438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03064438, "Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03064438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*